How a new Denmark tariff could impact Novo Nordisk

(2:49)

The spirit of our founders: The values and mindsets that created Novo Nordisk a century ago

(24:15)

CEO DIALOGUE #35 - Lars Fruergaard Jørgensen, Novo Nordisk

(49:8)

Novo Nordisk Stock Analysis! Buying Opportunity?

(11:12)

Novo Nordisk (Ozempic)

(3:45:26)

Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging

(4:8)

CagriSema still keeps the Novo Nordisk story in tact, says Barclays' Emily Field

(4:8)

How Ozempic And Wegovy Accidentally Made Novo Nordisk A $400B Company

(19:20)

Life-changing careers at Novo Nordisk

(1:40)

How Novo Nordisk built an empire selling diabetes and weight-loss drugs

(2:16)

NBC News Exclusive: Ozempic and Wegovy Novo Nordisk CEO speaks out on high prices, drug shortages

(4:29)

Novo Nordisk stock plunges on obesity shot trial results

(3:25)

Novo Nordisk CEO testifies before Senate on weight loss drug prices

(1:55)

Novo Nordisk CEO defends high price off Ozempic and Wegovy

(5:)

BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

(4:1econd)

Novo Nordisk plunges after obesity drug trial disappoints | REUTERS

(1:31)

How to use NovoPen 4

(6:46)

Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

(4:47)

Novo Nordisk CEO on Catalent, Ozempic and Wegovy

(13:6)